Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

USA - NASDAQ:SLAB - US8269191024 - Common Stock

131.08 USD
-0.66 (-0.5%)
Last: 10/31/2025, 8:13:57 PM
131.08 USD
0 (0%)
After Hours: 10/31/2025, 8:13:57 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to SLAB. SLAB was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. While SLAB has a great health rating, there are worries on its profitability. While showing a medium growth rate, SLAB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

SLAB had negative earnings in the past year.
SLAB had a positive operating cash flow in the past year.
In multiple years SLAB reported negative net income over the last 5 years.
In multiple years SLAB reported negative operating cash flow during the last 5 years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

Looking at the Return On Assets, with a value of -8.57%, SLAB is doing worse than 72.32% of the companies in the same industry.
SLAB has a Return On Equity of -9.86%. This is in the lower half of the industry: SLAB underperforms 66.96% of its industry peers.
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

SLAB has a better Gross Margin (54.95%) than 75.89% of its industry peers.
In the last couple of years the Gross Margin of SLAB has declined.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

8

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SLAB has more shares outstanding
The number of shares outstanding for SLAB has been reduced compared to 5 years ago.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SLAB has an Altman-Z score of 17.98. This indicates that SLAB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 17.98, SLAB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 17.98
ROIC/WACCN/A
WACC11.78%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 5.12 indicates that SLAB has no problem at all paying its short term obligations.
With a decent Current ratio value of 5.12, SLAB is doing good in the industry, outperforming 76.79% of the companies in the same industry.
A Quick Ratio of 4.45 indicates that SLAB has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.45, SLAB is in the better half of the industry, outperforming 77.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.12
Quick Ratio 4.45
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.76% over the past year.
SLAB shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.65%.
SLAB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.28% yearly.
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%

3.2 Future

Based on estimates for the next years, SLAB will show a very strong growth in Earnings Per Share. The EPS will grow by 64.51% on average per year.
SLAB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.71% yearly.
EPS Next Y143.45%
EPS Next 2Y86.42%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue Next Year34.95%
Revenue Next 2Y26.81%
Revenue Next 3Y22.71%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

SLAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 51.66, SLAB can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as SLAB.
When comparing the Price/Forward Earnings ratio of SLAB to the average of the S&P500 Index (22.55), we can say SLAB is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 51.66
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, SLAB is valued a bit cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 57.31
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SLAB's earnings are expected to grow with 64.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.42%
EPS Next 3Y64.51%

0

5. Dividend

5.1 Amount

SLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SILICON LABORATORIES INC

NASDAQ:SLAB (10/31/2025, 8:13:57 PM)

After market: 131.08 0 (0%)

131.08

-0.66 (-0.5%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners101.89%
Inst Owner Change-0.22%
Ins Owners1.87%
Ins Owner Change2.15%
Market Cap4.30B
Revenue(TTM)703.20M
Net Income(TTM)-104614000
Analysts74.12
Price Target152.87 (16.62%)
Short Float %4.71%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.72%
Min EPS beat(2)12.85%
Max EPS beat(2)16.59%
EPS beat(4)3
Avg EPS beat(4)16.76%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)6
Avg EPS beat(8)13.41%
EPS beat(12)8
Avg EPS beat(12)11.9%
EPS beat(16)12
Avg EPS beat(16)23.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)-1.26%
Revenue beat(8)1
Avg Revenue beat(8)-0.77%
Revenue beat(12)2
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0.42%
PT rev (3m)6.58%
EPS NQ rev (1m)1.1%
EPS NQ rev (3m)27.7%
EPS NY rev (1m)1.38%
EPS NY rev (3m)15.13%
Revenue NQ rev (1m)0.13%
Revenue NQ rev (3m)1.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.66
P/S 6.12
P/FCF 57.31
P/OCF 45.38
P/B 4.05
P/tB 6.55
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)2.54
Fwd EY1.94%
FCF(TTM)2.29
FCFY1.75%
OCF(TTM)2.89
OCFY2.2%
SpS21.43
BVpS32.33
TBVpS20.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.57%
ROE -9.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.95%
FCFM 10.68%
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 44.06%
Cap/Sales 2.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.12
Quick Ratio 4.45
Altman-Z 17.98
F-Score6
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%119.64%
EPS Next Y143.45%
EPS Next 2Y86.42%
EPS Next 3Y64.51%
EPS Next 5YN/A
Revenue 1Y (TTM)29.65%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%32.66%
Revenue Next Year34.95%
Revenue Next 2Y26.81%
Revenue Next 3Y22.71%
Revenue Next 5YN/A
EBIT growth 1Y32.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.24%
EBIT Next 3Y63.12%
EBIT Next 5YN/A
FCF growth 1Y563.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y724.28%
OCF growth 3YN/A
OCF growth 5YN/A

SILICON LABORATORIES INC / SLAB FAQ

What is the ChartMill fundamental rating of SILICON LABORATORIES INC (SLAB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SLAB.


Can you provide the valuation status for SILICON LABORATORIES INC?

ChartMill assigns a valuation rating of 3 / 10 to SILICON LABORATORIES INC (SLAB). This can be considered as Overvalued.


How profitable is SILICON LABORATORIES INC (SLAB) stock?

SILICON LABORATORIES INC (SLAB) has a profitability rating of 1 / 10.